Company
ARSYNL Rx
ARSYNL Rx publishes compounded tirzepatide at $256.33 a month — Tirzepatide HypoSpray (transdermal, needle-free).
- 1 program
- 1 molecule
- 1 reading
Read from arsynl.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to ARSYNL Rx
We earn nothing from this link. ARSYNL Rx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Tirzepatide HypoSpray (transdermal, needle-free)
Terms
| Pharmacy | The Pharmacy Hub; Chemistry Rx; Vital Rx; Optimal Balance Pharmacy; Center City Pharmacy; Olympia Pharmacy |
|---|
Not yet checked: membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Tirzepatide is sold in two formats: a standard injectable at $233/mo and a needle-free transdermal 'HypoSpray' at $256.33/mo. The HypoSpray's delivery method (a metered transdermal spray) does not match any of the schema's form options (not an injection, oral tablet, or sublingual placement), so it was recorded as not-disclosed with this note. Neither injectable product page states vial vs. pen.
Before you act
Cite this
Treatment Registry. (2026). ARSYNL Rx: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/arsynl-rx